We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VTVT market cap is 54.28M. The company's latest EPS is USD -5.7792 and P/E is -2.94.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1M | 0 | 0 | 17k | 0 |
| Operating Income | -5.63M | -7.16M | -6.51M | -4.89M | -6.5M |
| Net Income | -4.87M | -5.18M | -4.78M | -3.63M | -5.09M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.41M | 4.01M | 2.02M | 0 | 1.02M |
| Operating Income | -11.85M | -21.66M | -22.54M | -25.5M | -24.18M |
| Net Income | -8.5M | -12.99M | -19.16M | -20.25M | -18.46M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 54.18M | 46.46M | 43.16M | 38.27M | 32.03M |
| Total Liabilities | 28.2M | 26.02M | 25.25M | 23.97M | 23.13M |
| Total Equity | 25.99M | 20.44M | 17.91M | 14.3M | 8.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.79M | 25.47M | 33.24M | 11.02M | 38.27M |
| Total Liabilities | 11M | 10.25M | 27.4M | 29.57M | 23.97M |
| Total Equity | -80.1M | -9.74M | -10.74M | -24.68M | 14.3M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.34M | -14.06M | -20.48M | -25.31M | -5.69M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 50.14M | 50.14M | 52.61M | 52.61M | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18M | -19.31M | -16.02M | -19.08M | -25.31M |
| Investing | N/A | N/A | -21k | 4.4M | N/A |
| Financing | 19.47M | 26.98M | 14.75M | 12M | 52.61M |
| Market Cap | 54.28M |
| Price to Earnings Ratio | -2.94 |
| Price to Sales Ratio | 53.36 |
| Price to Cash Ratio | 1.48 |
| Price to Book Ratio | 3.8 |
| Dividend Yield | - |
| Shares Outstanding | 3.19M |
| Average Volume (1 week) | 6.25k |
| Average Volume (1 Month) | 9.89k |
| 52 Week Change | -29.56% |
| 52 Week High | 26.99 |
| 52 Week Low | 12.1201 |
| Spread (Intraday) | 17.74 (59.13%) |
| Company Name | vTv Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://vtvtherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
